Richard Pye | Investor Relations |
Glyn Edwards | Chief Executive Officer |
David Roblin | Chief Operating Officer and President of Research & Developments |
Erik Ostrowski | Chief Financial Officer |
Hartaj Singh | Oppenheimer |
Tim Chiang | BTIG |
Julie Simmonds | Panmure Gordon & Co |
Yun Zhong | Janney Montgomery |
Arlinda Lee | Canaccord Genuity |
Good day. And welcome to the Summit Therapeutics' Plc Financial Results for Quarter Two ended, 31 of July 2018 and Operational Update Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Richard Pye.